Pharma middlemen to propose changes to avoid regulations from Trump administration, Bloomberg News reports

Reuters
Sep 25
Pharma middlemen to propose changes to avoid regulations from Trump administration, Bloomberg News reports

Sept 24 (Reuters) - Pharmacy middlemen are working on a proposal to change some of their business practices to avoid new regulation from the Trump administration, Bloomberg News reported on Wednesday, citing people familiar with the discussions.

(Reporting by Siddhi Mahatole in Bengaluru)

((siddhi.mahatole@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10